User profiles for Paul W. Blair
 | Paul W BlairVanderbilt University Medical Center Verified email at vumc.org Cited by 551 |
[HTML][HTML] Durable SARS-CoV-2 B cell immunity after mild or severe disease
Multiple studies have shown loss of severe acute respiratory syndrome coronavirus 2–specific
(SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral …
(SARS-CoV-2–specific) antibodies over time after infection, raising concern that humoral …
The clinical course of COVID-19 in the outpatient setting: a prospective cohort study
PW Blair, DM Brown, M Jang, AAR Antar… - Open forum …, 2021 - academic.oup.com
Background Outpatient coronavirus disease 2019 (COVID-19) has been insufficiently
characterized. To determine the progression of disease and determinants of hospitalization, we …
characterized. To determine the progression of disease and determinants of hospitalization, we …
Durability of SARS-CoV-2–specific T-cell responses at 12 months postinfection
Background Characterizing the longevity and quality of cellular immune responses to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enhances understanding of …
… cytokine and chemokine dysregulation in hospitalized children with acute coronavirus disease 2019 and multisystem inflammatory syndrome with similar levels of …
Background Multisystem inflammatory syndrome in children (MIS-C) is a severe clinical
phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that …
phenotype of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection that …
[HTML][HTML] Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute …
Introduction The incidence of long COVID is substantial, even in people with mild to moderate
acute COVID-19. The role of early viral kinetics in the subsequent development of long …
acute COVID-19. The role of early viral kinetics in the subsequent development of long …
Differential cytokine signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza infection highlight key differences in pathobiology
…, L Sauer, K Shaw-Saliba, PW Blair… - Clinical Infectious …, 2022 - academic.oup.com
Background Several inflammatory cytokines are upregulated in severe coronavirus disease
2019 (COVID-19). We compared cytokines in COVID-19 versus influenza to define …
2019 (COVID-19). We compared cytokines in COVID-19 versus influenza to define …
Self-collected oral fluid saliva is insensitive compared with nasal-oropharyngeal swabs in the detection of severe acute respiratory syndrome coronavirus 2 in …
…, DM Brown, TT Sewell, A Antar, PW Blair… - Open Forum …, 2021 - academic.oup.com
Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
control will require widespread access to accurate diagnostics. Salivary sampling circumvents …
control will require widespread access to accurate diagnostics. Salivary sampling circumvents …
[HTML][HTML] Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial.
BACKGROUND: The efficacy of SARS-CoV-2 convalescent plasma (CCP) for preventing
infection in exposed, uninfected individuals is unknown. CCP might prevent infection when …
infection in exposed, uninfected individuals is unknown. CCP might prevent infection when …
COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment
Background We evaluated clinical outcomes, functional burden, and complications 1 month
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
after coronavirus disease 2019 (COVID-19) infection in a prospective US Military Health …
Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded …
Background The efficacy of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
convalescent plasma (CCP) for preventing infection in exposed, uninfected individuals is …
convalescent plasma (CCP) for preventing infection in exposed, uninfected individuals is …